Silo Pharma (NASDAQ:SILO) Issues Earnings Results

Silo Pharma (NASDAQ:SILO) released its earnings results on Friday. The company reported ($0.23) EPS for the quarter, Zacks reports. Silo Pharma had a negative return on equity of 61.38% and a negative net margin of 5,255.05%. The company had revenue of $0.02 million during the quarter.

Silo Pharma Price Performance

Shares of Silo Pharma stock opened at $0.81 on Friday. Silo Pharma has a 1 year low of $0.71 and a 1 year high of $4.50. The firm’s 50-day moving average is $1.11 and its 200 day moving average is $1.22. The stock has a market cap of $3.65 million, a price-to-earnings ratio of -0.70 and a beta of 0.37.

About Silo Pharma

Silo Pharma Inc operates as a developmental stage biopharmaceutical company. The company is developing therapeutics that address underserved conditions, including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in formulations and drug delivery systems.